SynVivo is a 3D Tissue and Organ-on-Chip developer whose models accelerate real-time studies of cellular behavior, drug delivery, and drug discovery by providing a biologically realistic microenvironment that more accurately depicts in vivo reality. SynVivo's models recreate complex in vivo microvasculature including scale, morphology, hemodynamic shear stress, and cellular interactions in an in vitro microfluidic chip environment and enable real-time visualization and quantitation.
SynVivo's proprietary microfluidic technology links the high-tech domains of microfluidics and bioengineering for broad applications in the life science arena. SynVivo microfluidic chips mimic the microvascular environment for culturing cells that retain many of the features found in human tissues and organs.
This microfluidic platform has the potential to be a game-changer for diseases like cancer as it enables the use of cells from patient biopsies to replicate the tumor environment for testing the efficacy of drugs or drug combinations—thus providing a novel personalized medicine approach to cancer therapy.
Company Details
- Employees
- 8
- Founded
- -
- Address
- 601 Genome Way, Huntsville,alabama 35806,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.synvivobio.com
- Keywords
- in drug discovery.
- HQ
- Huntsville, Alabama
Synvivo, Inc Questions
Synvivo, Inc's website is http://www.synvivobio.com
Synvivo, Inc's LinkedIn profile is https://www.linkedin.com/company/synvivo
Synvivo, Inc has
8 employees.
View email and phone details for 8
employees at Synvivo, Inc.
Synvivo, Inc's industry is
Biotechnology Research
Synvivo, Inc's top competitors are
Alveolix,
Cherry Biotech,
Netri,
Tissuse Gmbh,
Obatala Sciences,
Insphero,
Axosim,
Emulate, Inc.,
Hesperos Inc.,
Mimetas.
Synvivo, Inc's categories are Biotechnology Research
Synvivo, Inc's founding year is 2015
